Home » Newsletters » BioWorld Science

BioWorld Science

March 18, 1998

View Archived Issues

Ono's new MMP inhibitors

Ebselen: neuroprotective agent in patients with neurological deficits after aneurysmal hemorrhage

Stavudine versus zidovudine therapy in HIV-1-infected pediatric patients

Spironolactone and Diane 35 may have synergistic effects in hirsutism

ARL-15849KF: a selective CCK-A agonist for the treatment of eating disorders

Efficacy and safety of long-term donepezil in patients with mild to moderate AD

Company Profile: CeNeS

Sumitomo claims compounds for treating reperfusion injury

Xenova: year-end 1997 highlights

Ribi ImmunoChem and Schering-Plough sign distribution agreement for Melacine

EchoGen up for discussion by CPMP and FDA advisory committee

Verapamil analogues reverse MDR in cancer cells

Indazole inhibitors of PDE IV and TNF from Pfizer

Lilly develops selective serotonergic agents

Lilly describes novel compounds for postmenopausal syndrome and related conditions

European patent covers Bayer's new HMG-CoA reductase inhibitors

Faes reveals new antihistamines

AII blocker prevents complications of hypertension in SHR

Taiwan researchers identify lead potassium channel opener selective for bladder

UPSA discloses antiinflammatory/analgesic 1,2-diarylindole derivatives

EntreMed's therapy for insufficient tissue oxygenation heading for clinic

Modified factor VII interrupts the coagulation cascade

Selective iNOS inhibitor improves hepatic circulation and oxygen metabolism in sepsis

Cambridge NeuroScience remains optimistic about the potential of Cerestat

Still hot news: Immunex's Enbrel

Cel-Sci expands North American clinical trial for Multikine

Morphogenesis awarded phase I SBIR grant

Anticancer drug discovery collaboration initiated by Tripos, MDS Panlabs and Cell Pathways

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...